Browse our latest news and see which events we will be attending.


England Reaches a Genomics Milestone with Routine DNA testing Across the Country

A huge leap forward has occurred in precision medicine: NHS cancer and other disease patients in England will be offered routine genomic testing starting as early as October of this year. This is the first health service of this kind, being offered in the world and is being built on the foundation laid by the… Learn More

Bluebee Achieves ISO 13485 Medical Device Quality Standard Certification

Rijswijk, The Netherlands June 15, 2018 – Bluebee, a global bioinformatics solutions provider, has announced today that it has been awarded the ISO 13485:2016 certification. ISO 13485 is an internationally recognized medical device quality management systems standard, which was awarded to Bluebee for its design and development of software solutions and data processing algorithms intended for use… Learn More

Lexogen and Bluebee Collaborate to Streamline QuantSeq-UMI Sequencing Data Analysis Pipeline

VIENNA, AUSTRIA, AND RIJSWIJK, THE NETHERLANDS, June 12, 2018 – Lexogen, a transcriptomics and next-generation sequencing company and Bluebee, a global bioinformatics platform, have announced today the implementation of QuantSeq Unique Molecular Identifiers (UMI) data analysis pipeline on the Bluebee genomics analysis platform. This collaboration offers QuantSeq users utilizing UMIs the opportunity to analyze samples… Learn More

Bluebee introduces BLUEBASE, a streamlined solution transforming data into actionable knowledge for clinical and translational genomics research

RIJSWIJK, THE NETHERLANDS, May 16, 2018 — Bluebee Corporation announced today the release of BLUEBASE, a complete data management solution designed to transform next-generation sequencing (NGS) and metadata into actionable genomic knowledge with efficiency and clinical-grade security. BLUEBASE runs on the Bluebee core data analysis platform and provides post-sequencing intelligent data aggregation, ease of querying,… Learn More

Data Analysis, Aggregation And Management Have an Essential Role to Play in Gaining Insights and Wisdom From Genomic Data

Precision Medicine Forum Editor Mark Glover spoke to the Bluebee’s CEO Hans Cobben (pictured) about enabling and facilitating the potential of precision medicine through data analysis. Bluebee offers an advanced global bio-informatics platform to analyse, share and store genomics data. It supports users in clinical diagnostics, pharma and research with advanced analytics for genomic discovery that will… Learn More

New England Biolabs and Bluebee Partner to Deliver an End-To-End Data Analysis Solution for NEBNext Direct Target Enrichment

RIJSWIJK, The Netherlands & Ipswich, Massachusetts, USA — February 8, 2018 – Bluebee, a company driving global genomic data-driven medicine, and New England Biolabs, Inc. (NEB®) have partnered to provide a secure and convenient data processing solution for NEB’s NEBNext Direct target enrichment technology. Through this partnership, Bluebee enables NEB’s NEBNext Direct customers the ability… Learn More

Agendia and Bluebee Partner to Bring New NGS-Based MammaPrint® BluePrint® Breast Cancer Kit to Market

RIJSWIJK, NETHERLANDS and IRVINE, CA, AMSTERDAM, – 19 December 2017 – Bluebee, a company driving global genomic data-driven medicine, and Agendia, Inc, a world leader in personalized medicine and molecular cancer diagnostics, have partnered to provide a secure, convenient, data processing solution for Agendia’s MammaPrint BluePrint Breast Cancer Recurrence and Molecular Subtyping Kit, which is… Learn More

Bluebee adds NEN 7510:2011 Certification to its Security Portfolio

The security of Bluebee’s customer data is a priority highlighted by the recent NEN 7510:2011 certification, and demonstrates the company’s continued strive for security compliance and excellence in handling healthcare data. The NEN 7510:2011 standard is the Dutch standard detailing requirements on information security for organizations processing and managing patient data. Required by the Ministry… Learn More

SLAMdunk – Another Optimized Lexogen, Bluebee Pipeline to Simplify Data Analysis

In September this year, Lexogen released the family of SLAMseq Metabolic RNA labeling kits, the underlying methodology of which is based on S4U labeling of RNA in cell cultures, alkylation of RNA with iodoacetamide, and the consequent introduction of T to C mutations in cDNA. To simplify the data analysis component for users of the SLAMseq… Learn More

Lexogen and Bluebee Partner to Bring the SLAMseq Metabolic RNA Sequencing Data Analysis Pipeline to the Users

RIJSWIJK, The Netherlands and Vienna, Austria — November 10, 2017 — Bluebee, a company driving genomic data-driven medicine, and Lexogen a company enabling the analysis of the complete transcriptome, announce the successful integration of the SLAMdunk pipeline on Bluebee’s private cloud-based platform, making it available to analyze data generated by every user of the SLAMseq Metabolic… Learn More

Overcoming High Sequence Complexity with the PacBio De Novo Assembly Pipeline, on the Bluebee Platform

Complex elements – repetitive regions, copy number variants, or structural variations – are challenging, if not impossible to sequence using short-read technologies. PacBio’s long-read technology based on Single Molecule, Real-Time (SMRT) sequencing, delivers long reads with uniform coverage, allowing comprehensive de novo genome assemblies that can overcome the short-read sequencing challenges of complex DNA regions…. Learn More

ASHG 2017 was all About Expediting the Analysis and Interpretation of Research and Clinical Data

The theme of this year’s annual gathering of geneticists at the American Society of Human Genetics conference held in Orlando was centered around expediting the analysis and interpretation of both research and clinical data. The conference kicked off with a talk by ASHG President Dr. Nancy Cox, highlighting the need for diversity in genetic studies to… Learn More


RIJSWIJK, The Netherlands and MENLO PARK, Calif., — October 9th, 2017 — Bluebee, a company driving genomic data-driven medicine, and Pacific Biosciences of California, Inc. (NASDAQ:PACB), the leader in long-read sequencing, announced they have integrated the PacBio® de novo assembly pipeline onto the Bluebee® genomics analysis platform. The integration creates a simplified workflow and fully… Learn More

Join the Bluebee and PacBio® expert hours at ASHG

At this year’s gathering of human geneticists at ASHG, Bluebee will seize the opportunity to highlight our latest developments and our newly established collaboration with PacBio, making their “de novo sequencing pipeline” instantly accessible for Bluebee users. This HGAP4 pipeline simplifies the workflow and offers a fully automated, end-to-end, data analysis solution, for the assembly… Learn More

Homing in on Clinically Relevant Variants with the Bluebee Annotation Reference Pipeline

Available to all Bluebee users, the Bluebee Annotation Reference Pipeline enables the identification of a large number of genetic variants from a single sequencing experiment. Understanding the clinical relevance of the identified variants in any genetic dataset critically depends on annotating those variants with the proper information. To ensure a fast and efficient variant annotation… Learn More

Bluebee Just Received Another Security Stamp of Excellence

We at Bluebee are excited to have achieved CSA STAR Assessment Level 1 which demonstrates our ongoing commitment to the platform and data security. The Cloud Security Alliance (CSA) – a non-profit organization launched in 2009 – is the world’s leading organization dedicated to defining and raising awareness of best practices to help ensure a secure… Learn More

Pushing the data boundaries to advance healthcare

Over the last two weeks, the Bluebee team attended both Bio-IT 2017 in Boston and the European Society for Human Genetics conference, ESHG, in Copenhagen, Denmark. These events were content-rich, once more demonstrating that the field of next-generation sequencing has matured and is steadily moving towards addressing both existing and new challenges associated with large… Learn More

Bluebee and MediSapiens Announce Strategic Partnership

Combined Offering Provides a Comprehensive Integrated Solution For (NGS) Data Analysis And Interpretation in Healthcare And Research Finland and The Netherlands – May 29, 2017 – Today, Bluebee, a leading provider of high-performance genomics analysis and storage solutions and MediSapiens, a leading biomedical big data curation, management and interpretation company, announce a strategic partnership to… Learn More

Delivering a seamless end-to-end RNA-seq solution

We are excited to release a new case study that focuses on complete end-to-end solution delivery in partnership with Lexogen, a Vienna-based company, and the provider of innovative RNA transcriptomics solutions for next generation sequencing (NGS) protocols. Not only does this case study highlight the benefits for the end-user of kit solutions that are faced… Learn More

Bluebee Appoints two Independent Board Members

Boston, MA & Rijswijk, The Netherlands – May 5, 2017 Bluebee Holding BV a leading provider of high performance genomics solutions, today announced the appointment of two new members to its Board of Directors. Lars Kongsbak has been appointed as an independent director, and Nicolas Roelofs will become Chairman of the Board. About Nicolas H… Learn More

Bluebee, together with IBM, discovers defects in your DNA

The article (in Dutch) highlights how Bluebee is responding to the analyse needs, and secure storage requirements of huge amounts of genetic data. Using technology such as cloud computing and supercomputing, which in turn links to the Watson computer system from IBM the Bluebee solution can use the data for the identification and treatment of disease… Learn More

Another Information-Rich AACR Meeting is Over – Many Insights on Advancing Cancer Research Gained

This year’s AACR meeting achieved record attendance with more than 21,900 researchers, physicians, and commercial providers gathering in Washington DC for the annual event.  What an exciting meeting, filled with innovative science and optimism for the field’s future. Cancer research is a vast and complex undertaking that involves researchers from many different disciplines and across… Learn More

RNGS17 – Was About Using Sequencing Data to better Understand the Biology behind Disease

The 2nd edition of the Revolutionizing Next-Generation Sequencing conference took place last week in Antwerp, Belgium. This VIB conference has quickly grown into a reputable event with a remarkable set of talks. It is very encouraging to see that this conference – a local one for us – which we sponsored attracted a truly global… Learn More

Bluebee Awarded With The Frost And Sullivan 2017 Enabling Technology Leadership Award

Today we announced that Bluebee has been awarded the Frost & Sullivan 2017 European Enabling Technology Leadership Award. Each year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that enhances current products and enables the development of new products and applications that address global challenges. We are honored… Learn More

Bluebee Compliance Officer invited to be part of Data Protection and GDPR panel

On 7th March 2017, Bluebee Compliance Officer, Sophia Kankuah was one of the panellists at the Data Protection & GDPR conference that took place in Antwerp, Belgium. Bluebee, is a provider of a private cloud-based accelerated genomics platform with state-of-the-art data security and regulatory compliance.  Sophia shared her experience about the new General Data Protection… Learn More

Our First AGBT Attendance Was Fantastic

Looking back on the annual Advances in Genome Biology & Technology (AGBT) conference, held this year at Hollywood Beach, I must conclude I had an amazing time at this very unique event. The scientific talks were of top caliber and the networking opportunities over lunch and drinks were most valuable. I learned first-hands about the… Learn More

Bluebee Selected as a 2017 IBM Beacon Awards Finalist

It is a great honor that Bluebee was selected as an IBM Beacon Awards Finalist in the category of “Outstanding Innovation on Cloud Infrastructure”. The 2017 Beacon Awards recognizes IBM Business Partners around the globe for their innovative use of IBM offerings, technical excellence, and resulting client satisfaction. This is a great achievement for the entire… Learn More

Bluebee as an IBM Partner Drives Global Cloud Momentum with Bluemix

Today, IBM shared some of its clients’ success stories with global partners, that drive the global cloud momentum based on Bluemix, at the PartnerWorld Leadership Conference (PWLC) held in Las Vegas. We are honored to have been called out by IBM as a participating company in this Bluemix announcement. IBM Bluemix enables developers and Business… Learn More

Has a New Era of Next-Generation Sequencing Begun?

Bluebee featured in an article by Tal Behar, Co-founder and President of PMWC Intl. “The answer is most probably yes. Here is why, but don’t just take our word for it, also plan on attending PMWC 2017 Silicon Valley to learn first-hand what the field is up to and what we can expect in 2017…. Learn More

Bluebee to Present at Precision Medicine World Conference 2017

The annual Precision Medicine World Conference (PMWC) will take place in Mountain View, CA, January 23 – 25, 2017. This established conference attracts over 1,200 global attendees consisting of recognized thought leaders, top global researchers and medical professionals, and innovators from across healthcare and the biotechnology sector. We are excited to have an active presence… Learn More

Happy New Year – May it be a Successful One!

First off, I want to wish all a wonderful, healthy, and successful 2017! We at Bluebee had a great and exciting 2016 with the continuous success of our European product rollout, our platform security confirmation with ISO27001, IGSOC, and HIPAA certification, the opening of our office in Boston, the signing on of first US customers,… Learn More

A very merry Christmas from the Bluebee team

It is this time of the year when we look back at what we have achieved in 2016, and what a year it was for the Bluebee team: we rolled-out our genomics platform at top institutes and service providers in Europe, opened our US office in Boston, registered the first set of US customers, achieved… Learn More

Bluebee Featured in IBM Cloud Computing News

Kurt Florus, CTO at Bluebee talks about the strategic partnership between Bluebee and IBM in a guest blog in “Thoughts on Cloud” in IBM Cloud Computing News. Click here to read the blog.

Bluebee Achieves HIPAA Compliance, The Highest Standards of Confidentiality and Data Protection

Just announced today, the Bluebee Genomics Platform has achieved compliance with all data security safeguards outlined in the Health Insurance Portability and Accountability Act (HIPAA). The HIPAA Security and Privacy safeguards are designed to protect Protected Health Information (PHI) for all customer data uploaded to the Bluebee Genomics Platform. This achievement was validated by an… Learn More

Webcast: Driving the Advancement of Precision Medicine and Genomic Sequencing

Progress towards novel therapeutics and diagnostic applications in oncology and rare diseases is reaching new heights with new innovative next-generation sequencing technologies. These include, but are not limited to advancements in bioinformatics, next-generation sequencing for pathogen detection, nanosensor technology for genome sequencing and healthcare diagnostics, molecular indexing technology for digital detection of single cells, and… Learn More

Combining Lexogen with Bluebee: RNA-Seq Analysis Simplified

Lexogen – Bluebee webinar: To make your life easier we simplified the entire process from RNA-Seq library preparation to gene expression analysis by combining Lexogen QuantSeq 3’ mRNA-Seq – the fastest, most effective, and cost-efficient library prep for gene expression analysis – with the flexible, secure, and high performance Bluebee Genomics Platform. With each Lexogen… Learn More

Bluebee to Present an Efficient, Accelerated BWA-MEM at ReConFig 2016

ReConFig 2016 is a leading forum for both researchers and engineers for the exchange of information around reconfigurable computing and FPGA technology, which is taking place November 30 to December 2 in Cancun, Mexico. A great opportunity not only to soak in the sun, but also to take in the recent advancements and innovations around… Learn More

Bluebee Sucessfully Obtains Information Governance Statement of Compliance

Today we announced the Bluebee Genomics Platform and its associated processes for development and operations have successfully obtained the Information Governance Statement of Compliance (IG SoC) which includes compliance with the NHS Information Governance Toolkit. The NHS has developed its own set of rigorous information governance principles to ensure a consistent approach to the management… Learn More

Lexogen And Bluebee Collaborate To Simplify Gene Expression RNA-Seq Data Analysis

Transcriptomics and next generation sequencing company Lexogen and Bluebee are collaborating to make the QuantSeq data analysis pipeline on the Bluebee genomics analysis platform. Lexogen’s QuantSeq 3’ mRNA-Seq Library Prep Kit has already been recognized as one of the fastest, most cost-efficient, and accurate methods for expression profiling using next generation sequencing. It is also… Learn More

DNA analysis is the heart of every hospital

In Belgium, a consortium of key academic institutions, university hospitals and innovative technology players have joined forces to build a next generation genomics platform. Bluebee is a key partner in this large scale initiative. IMEC, recently merged with iMinds and since many years a pinnacle of early stage innovation in the micro-electronics field, Leuven and… Learn More

CB Insight report on The Digital Hospital recognizes Bluebee

CB Insight report on The Digital Hospital recognizes Bluebee as one of 80 + companies reinventing medicine.  Digital health companies vary widely in the user base they’re targeting, from physicians to athletes to insurers. In their report on The Digital Hospital CB Insights identified 82 private digital health companies – including Bluebee – that have a direct… Learn More

Bluebee Achieves ISO/IEC 27001:2013 Accreditation

At Bluebee we place the highest importance on data security and information governance, we are therefore pleased to announce that we have successfully achieved this major milestone. The ISO 27001:2013 certification is an independent confirmation of the strength of Bluebee’s information security management system (ISMS). Independent audit firm BSI has certified that the Bluebee Genomics Platform and the… Learn More

Start-up story:Accelerated DNA Analyses

Some experts say that clinical use of DNA analyses is the only way to keep our health care system affordable in the future. But unravelling ones DNA is a bit like trying to find spelling mistakes in a newspaper that has been shredded into billions of pieces. Bluebee is using supercomputing technology to put the… Learn More

San Diego Festival of Genomics Summary

On 20th-21st September, Bluebee exhibited at the Festival of Genomics in the beautiful city of San Diego, California. According to the mayor of San Diego, this city is becoming the Genomics Capital of the World, since it is hosting a growing number of biotech companies, currently about 800. Hence, San Diego was the ideal location to… Learn More

Leading Sequencing Service Provider GATC Biotech Adopts Bluebee for Genomic Analysis

GATC Biotech, Europe’s leading provider of sequencing and bioinformatics solutions, has adopted Bluebee’s robust and scalable cloud platform to support secure, efficient and affordable data analysis. GATC will leverage the Bluebee platform to support large scale services, such as whole genome sequencing. The partnership is part of a systematic effort to offer the fastest processing… Learn More

IBM Power Systems Workshop on High Throughput Sequencing

It was a wonderful opportunity for us to be part of this workshop in Barcelona, Spain earlier this week. Organized by the IBM Power Systems‘ team more than 60 attendees were treated to numerous presentations, resulting in a wealth of information sharing. After a kind welcome by Miguel Muños of the local IBM team, Ana Ripoll,… Learn More

Bluebee Opens a New Corporate Office in Boston, MA

After a fruitful year of introducing our cloud-based high performance genomics solutions in the United States and Canada, we have established close relationships with major research and clinical labs in the region. With the opening of our new office, we are excited to demonstrate our increased commitment to service them even better. From our Boston… Learn More

ECCB 2016 Sum Up

The Bluebee team attended the 15th European Conference on Computational Biology in The Hague, September 3-7 2016. This has been a fantastic combination of cutting edge keynote presentations from prestigious institutions around the world, and parallel tracks focusing on various themes (Genomes, Systems, Data, Applications and others). A remarkable amount of effort is being provided… Learn More

How Big Data Drives Scientific Progress

What underlies disruptive scientific advancement? Does science progress best when a ‘theory-driven’ approach is being followed? Or is scientific progress rather driven by the development and introduction of new technologies that lead to the ‘sudden’ availability of phenomenal amounts of data? This question has never become more relevant in an era in which Big Data… Learn More

Webinar: How Bluebee Genomics Platform Solves the File Exchange Problem with Aspera FASP

As new research techniques create terabytes of NGS data, the need to quickly, easily, and securely ingest and exchange large genome data files with the cloud’s scale-up capacity becomes critical. Learn how Bluebee overcomes this challenge by using Aspera FASP technologies and solutions to securely move large files at high-speed to and from multiple cloud... Learn More

ESHG 2016 Sum Up

The Bluebee team participated in the annual European Society of Human Genetics in Barcelona, 21st- 24th May, 2016. Our team exhibited at booth 343, where we had numerous of interesting discussions with researchers, lab managers, and commercial directors. All professionals had the same goal: further unlock the huge potential of genetics. Many initiatives were presented... Learn More

Bluebee Introduces New Release with Integrated Genome Browser

The newly added features include the integration of The Broad Institute’s Integrative Genomics Viewer, the ability to add customer definable tags and metadata, as well as enhanced capabilities for flexible management of data storage. Integration of the Broad Institute’s Integrative Genomics Viewer (IGV) The Integrative Genomics Viewer ( is a high-performance visualization tool for interactive exploration of... Learn More

Accelerating Cancer Diagnostics Pipelines Using Technologies of OpenPOWER

Zaid Al-Ars, co-founder and scientific advisor of Bluebee presented the developments made in the Personalized Medicine Workgroup he chairs at the OpenPOWER Summit 2016 on 6th April in San Jose, CA. In this talk, he presented  the collaborative effort by a number of OpenPOWER members, coordinated by the PersMed workgroup, to bring together various technologies... Learn More

Bluebee unravels the genome, Kanaal Z

Invited by the financial and economic channel Kanaal Z on 15th April, our CEO Hans Cobben talks with Veronique Goossens.   Veronique starts with noting Hans' previous experience in the financial sector and how that knowledge positions Bluebee, a High Performance Genomics company, as a key player in the genomics industry. Hans then talks about... Learn More

Back from the Bio-IT World Conference in Boston

Last week we went to Boston for the Bio-IT World Conference 2016. The three days of the conference were packed with great exposure for Bluebee, exciting talks and excellent networking opportunities. Our booth was a busy place to be and to engage with our team of seven experts about the show, the current market view... Learn More

Hans Cobben, Bluebee’s CEO on BNR radio

Bluebee’s CEO Hans Cobben was a guest speaker on BNR radio's Entrepreneurs panel: "What to do with €10 million?" A recording (in Dutch) is available here.

Bluebee Teams Up With Aspera for Fast Transfer of Genomics Data for Clinical Applications

ARMONK, NY – April 5, 2016: IBM (NYSE:IBM) today announced that Bluebee, a leading provider of high-performance genomics solutions, has deployed high-speed file transfer solutions from Aspera, an IBM company, running on the IBM Cloud and integrated directly into the Bluebee genome analytics platform. Aspera transfers reduce the end-to-end turnaround time of computational data analysis, enabling... Learn More

Bluebee Announces €10 Million in Series A Financing

Bluebee announced today it has raised €10 million ($11,6 million) in Series A financing from a strategic group of investors active at the crossroads of life sciences and ICT, including Capricorn ICT Arkiv, Korys and Biover II. The financing was subscribed by Bluebee’s existing shareholders, including Buysse & Partners and the management team.  The investment will support... Learn More

Festival Of Genomics wrap-up

In January, we exhibited at the Festival of Genomics in London, overall a great success, with very good attendance on our booth and interesting speaker session.  The event ran very smoothly, although the cold weather wasn’t only outside on the streets of London but also decided to attend the event. With plenty of exhibitors and attendees we... Learn More

Bluebee adds NGS analysis framework to cloud genomics platform

Bluebee is making a next-generation sequencing (NGS) data analysis framework from the University of Cologne available on its cloud platform. The partners formed the collaboration to broaden the reach of a framework they see as cutting the time and effort it takes to analyze genomics data. Full article covered by FierceBiotech.

CECAD Cologne and Bluebee collaborate to expand access

Bluebee and the Bioinformatics Core Facility at the CECAD Research Center of the University of Cologne are collaborating to implement QuickNGS on Bluebee’s high-performance cloud platform for genomic analysis. In a society where people are living longer, the Cologne Cluster of Excellence (CECAD) at the University of Cologne explores aging-associated disorders and their causes. More than 400... Learn More

OpenPOWER Personalized Medicine Workshop summary

As part of the OpenPOWER Workgroup on Personalized Medicine, more than 40 interested attendees participated in the Personalized Medicine Workshop organized on Nov 14, 2015 in Austin (TX). The objective of the workshop was to bring together important players and address relevant issues in the field as well as chart future developments, challenges and opportunities.... Learn More

Bluebee Scientific Advisor wins a HiPEAC Tech Transfer Award 2015

Congratulations to Zaid Al-Ars for winning the HiPEAC Tech Transfer Award winner, an award that recognises the successful examples of technology transfers from academia to industry. HiPEAC is the European Network of Excellence on High Performance Architectures, which focusses on steering European research in the area of high-performance and embedded computing systems. The Tech Transfer Award... Learn More

Edmee van Dijk joins Bluebee as Chief Financial Officer

Bluebee announces that Edmée van Dijk is joining the company as Chief Financial Officer. Edmée joins Bluebee from the Alma mater and shareholder Delft University of Technology, where she was responsible for the investment portfolio of the university.  In this role, Edmée was a member of the board of directors of numerous spin-outs, including Bluebee.  Prior she worked in Venture Capital firm TIIN Capital and... Learn More

Big turnout for our Personalized Medicine workshop hosted in conjunction with IBM and OpenPOWER

On the eve of the Supercomputing conference SC15, the OpenPOWER Foundation, IBM and Bluebee co-hosted a workshop on Personalized Medicine in Austin, TX. The OpenPOWER Personalized Medicine Workshop reached out to the key players and stakeholders in the genomics field, to spur discussion, identify current trends and chart future challenges and opportunities. After the September announcement that Bluebee co-founder and scientific advisor Dr. Zaid... Learn More

Bluebee supports the annual charity event of Rotary Brussels Catersteen

Bluebee is sponsoring the annual charity event organised by Rotary Club Brussels Cantersteen. The event will take place on the Friday November 20th. The evening will be of entertaining nature: projecting the latest Bond Movie: SPECTRE starring high-performance Daniel Craig, Christoph Waltz, Ralph Feinnes  and Monica Belluci. The movie will be followed by a dinner at the prestigious BMW Brand... Learn More

TU Delft – Bluebee paper published at HPC-BCB workshop in Washington

We are pleased to announce that there will be a paper published at the High Performance Computing for Big Data Computational Biology workshop taking place between 9-12th November in Washington D.C. The event is in conjunction with IEEE International Conference on Bioinformatics and Biomedicine (BIBM) The paper – researched and written in a collaboration between Computer Engineering Lab at... Learn More

Eurotech-Computers partners with Bluebee

Eurotech-Computers partners with Bluebee to expand their offering in the life sciences sector. Bluebee’s  HPC-based genomics analysis platform fits perfectly with the Eurotech partner portfolio, consisting of some of the most respected and innovative companies in the industry. Bluebee’s private cloud-based and accelerated genomics analysis platform enables fast, efficient, compliant and affordable processing of large volumes of genome data.... Learn More

Rare Disease Focus

Earlier in September, Bluebee sponsored a Cambridge-based Rare Disease summit organised by a philanthropic-oriented non-for-profit organisation called Cambridge Rare Disease Network (CRDN). The one-day event was held at the Cambridge Judge Business School and featured 35 speakers and over 130 attendees. The summit attracted all active stake holders in the rare disease space including relatives of rare disease patients,... Learn More

Bluebee Featured on RTLZ: Future Makers

On 30th September Bluebee was featured in RTLZ TV series: “Toekomstmakers” Translated it is Future Makers: which is an informative program focused on leadership, innovation and inspiring entrepreneurs and scientists. This third episode focuses on life longevity: “We will soon be 150 years old? Some scientists think so. Why? Is our society ready for this?” The... Learn More

Bluebee to Chair OpenPOWER Personalized Medicine Work Group

We are proud to announce that Bluebee co-founder Dr. Zaid Al-Ars has been elected as chairman of the newly chartered OpenPOWER workgroup named the Personalized Medicine Workgroup.  The workgroup brings together technology leaders in the field and consolidates the efforts to create effective genomics computational solutions. Founding members of the workgroup are IBM, Altera Corporation, Nallatech and next generation sequencing data... Learn More

Conquering the mountains to support personalised cancer research

Proud to share with you that Edwin Cuppen, member of the Bluebee advisory board completed the challenge Stelvio For Life Foundation 2015 on Saturday 29th August. The Stelvio for Life Foundation mission is to rise money to support personalised cancer research, by organising (hard) walking and cycling events. Edwin completed the resent challenge which was 21.1... Learn More

Intel Invests US$50 Million to Advance Quantum Computing

Congratulations to Bluebee founder Prof. K.L.M Bertels from Delft University of Technology (TU Delft) for the $50M funding provided by Intel to advance research efforts in Quantum Computing. The collaboration along with TNO will span over 10 years and holds the promise of solving complex problems that are practically insurmountable today. Full article in Business... Learn More

Bluebee on television news

Belgian’s public network broadcasted a feature on Bluebee on the 7 o’clock news. Click here to watch the video (in Dutch)

Genomeweb’s view on the Bluebee solution

Bluebee Rolls Out Cloud-based, High-Powered Genomic Analysis Services in Europe Andrew P. Han NEW YORK (GenomeWeb) – With a management team derived from disparate parts of the IT field, Dutch informatics firm Bluebee may not look like the typical genome analytics vendor, but it has a lofty vision for a fragmented market, promising speed and... Learn More

Bluebee raises €1.75 million investment

Bluebee announced toady it has raised 1.75 million EUR (1.90 million USD) from Belgian investment firm Buysse & Partners and existing shareholder Delft University of Technology to bring its cloud-based, accelerated genomics solution to clinicians and labs. Bluebee’s technology, based on hybrid-core computing (FPGA) allows clinicians to shorten the time-to-diagnosis substantially. “Our technology solves the... Learn More

Top edition for the 6th 1000 km bike ride

3500 bikers, divided over 600 teams participated in this year’s edition of the “Kom op tegen Kanker” 1000km bike ride to raise money in the fight against cancer. Each cyclist in the teams cycled 125 km over the course of four 1000km bike rides to raise money . The event organized by the Flemish League... Learn More

Bluebee moves to YES!Delft as the company’s business grows

Bluebee has today moved its Delft staff into the YES!Delft business center. The new location will accommodate recent staff growth and provide a more flexible and accessible venue for meetings, product demonstrations and events. YES!Delft is the high tech entrepreneurs centre linked to the Technical University of Delft.

Dr. Marc Hogenbirk joins the Bluebee team

Bluebee announces the expansion of its senior management team with the appointment of Marc Hogenbirk, Ph.D. as Head of Product Management High Performance Genomics solutions. Marc joins Bluebee from the Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital (NKI-AVL) where he was project leader bio-informatics in oncology. He received his Ph.D. at the Netherlands Cancer... Learn More

Dr. Zaid Al-Ars wins TU Delft DIG-it Award

Bluebee’s Dr. Zaid Al-Ars has been awarded with the TU Delft DIG-it Award for his innovative work in accelerating DNA-analysis in cancer research. The jury selected the winner from over 700 projects, based on innovation, applicability and social impact. Congratulations Zaid ! Click here to read more on RTLZ (in Dutch)

Bluebee Joins the OpenPOWER Foundation

Bluebee has joined the OpenPOWER Foundation, an open development community that leverages the IBM POWER architecture. Bluebee is glad to join IBM, Google, Altera, Xilinx and a growing number of technology organizations working collaboratively to build advanced server, storage, and networking acceleration technology as well as industry leading open source software aimed at delivering more... Learn More

Convey Computer and Bluebee Partner to Strengthen Offering

Richardson, Texas and Delft, The Netherlands–September 8, 2014–Bluebee, a next generation sequencing data analysis provider and Convey Computer Corporation, the leader in hybrid-core computing for accelerating data analytics, today announced a distribution agreement that strengthens both companies’ bioinformatics offerings. The partnership promotes increased innovation for bioinformatics technologies and advanced solutions for next-generation sequencing research. The... Learn More



Bluebee is Exhibiting at ASHG 2018 in San Diego

Sharing discoveries and shaping the future is this year’s timely theme of the America Society of Human Genetics 2018 conference.  Happening in mid-October 16 – 20, 2018 – the event perfectly encapsulates a core Bluebee value: the power of interconnectedness.  The Bluebee platform has been designed to streamline and scale the delivery of whole solutions for assay… Learn More

Sign up for our newsletter

Our latest news, publications and developments delivered to your inbox